GL1X · GenesisL1 explorer

Research workbench

The crystal structure of JNK3 in complex with a phenantroline inhibitor

Analyse The crystal structure of JNK3 in complex with a phenantroline inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1PMU
Type
protein
Length
342 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mitogen-activated protein kinase 10
EC
2.7.1.-
UniProt
P53779
Ligands
9HP, CL
Pockets
1 · best druggability 0.62

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMitogen-activated protein kinase 10 (EC 2.7.1.-)protein34241% helix, 15% strandP53779

Ligands and binding sites

  • 9HP · 9-(4-hydroxyphenyl)-2,7-phenanthroline · ligand · chains A
  • CL · Chloride ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12880.620.80459HP

Compared structures

  • 1PMU · The crystal structure of JNK3 in complex with a phenantroline inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • P53779 · AlphaFold monomer V2.0 prediction for mitogen-activated protein kinase 10 (P53779) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.